Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 67 entries
Sorted by: Best Match Show Resources per page
Letter to the Editor.

Clinical and experimental hypertension (New York, N.Y. : 1993)

Chen X, Chen Z, Zeng X, Fu P.
PMID: 28513224
Clin Exp Hypertens. 2017;39(4):388. doi: 10.1080/10641963.2016.1259323. Epub 2017 May 17.

No abstract available.

Cite
Chen X, Chen Z, Zeng X, et al. Letter to the Editor. Clin Exp Hypertens. 2017;39(4):388doi: 10.1080/10641963.2016.1259323.
Chen, X., Chen, Z., Zeng, X., & Fu, P. (2017). Letter to the Editor. Clinical and experimental hypertension (New York, N.Y. : 1993), 39(4), 388. https://doi.org/10.1080/10641963.2016.1259323
Chen, Xiaohan, et al. "Letter to the Editor." Clinical and experimental hypertension (New York, N.Y. : 1993) vol. 39,4 (2017): 388. doi: https://doi.org/10.1080/10641963.2016.1259323
Chen X, Chen Z, Zeng X, Fu P. Letter to the Editor. Clin Exp Hypertens. 2017;39(4):388. doi: 10.1080/10641963.2016.1259323. Epub 2017 May 17. PMID: 28513224.
Copy Download .nbib Format: NLM
Synergistic effects of gene polymorphisms of the renin-angiotensin-aldosterone system on essential hypertension in Kazakhs in Xinjiang.

Clinical and experimental hypertension (New York, N.Y. : 1993)

Niu S, Zhang B, Zhang K, Zhu P, Li J, Sun Y, He N, Zhang M, Gao Z, Li X, Simayi A, Ge J, Cong M, Zhou W, Qiu C.
PMID: 26269000
Clin Exp Hypertens. 2015 Aug 13;1-8. Epub 2015 Aug 13.

OBJECTIVE: To assess the synergistic effects of gene polymorphisms of the renin-angiotensin-aldosterone system (RAAS) on essential hypertension (EH) in Kazakhs in Xinjiang.METHODS: A cross-sectional case-control association study was conducted in 52 1 hypertensive and 623 normotensive subjects of Kazakh...

Cite
Niu S, Zhang B, Zhang K, et al. Synergistic effects of gene polymorphisms of the renin-angiotensin-aldosterone system on essential hypertension in Kazakhs in Xinjiang. Clin Exp Hypertens. 2015;1-8
Niu, S., Zhang, B., Zhang, K., Zhu, P., Li, J., Sun, Y., He, N., Zhang, M., Gao, Z., Li, X., Simayi, A., Ge, J., Cong, M., Zhou, W., & Qiu, C. (2015). Synergistic effects of gene polymorphisms of the renin-angiotensin-aldosterone system on essential hypertension in Kazakhs in Xinjiang. Clinical and experimental hypertension (New York, N.Y. : 1993), 1-8.
Niu, Shudong, et al. "Synergistic effects of gene polymorphisms of the renin-angiotensin-aldosterone system on essential hypertension in Kazakhs in Xinjiang." Clinical and experimental hypertension (New York, N.Y. : 1993) vol. (2015): 1-8.
Niu S, Zhang B, Zhang K, Zhu P, Li J, Sun Y, He N, Zhang M, Gao Z, Li X, Simayi A, Ge J, Cong M, Zhou W, Qiu C. Synergistic effects of gene polymorphisms of the renin-angiotensin-aldosterone system on essential hypertension in Kazakhs in Xinjiang. Clin Exp Hypertens. 2015 Aug 13;1-8. Epub 2015 Aug 13. PMID: 26269000.
Copy Download .nbib Format: NLM
EDITORIAL RETRACTION.

Clinical and experimental hypertension (New York, N.Y. : 1993)

[No authors listed]
PMID: 30676090
Clin Exp Hypertens. 2021 Nov 17;43(8):801. doi: 10.1080/10641963.2018.1475654. Epub 2019 Jan 24.

No abstract available.

Cite
EDITORIAL RETRACTION. Clin Exp Hypertens. 2019;43(8):801doi: 10.1080/10641963.2018.1475654.
(2021). EDITORIAL RETRACTION. Clinical and experimental hypertension (New York, N.Y. : 1993), 43(8), 801. https://doi.org/10.1080/10641963.2018.1475654
"EDITORIAL RETRACTION." Clinical and experimental hypertension (New York, N.Y. : 1993) vol. 43,8 (2021): 801. doi: https://doi.org/10.1080/10641963.2018.1475654
EDITORIAL RETRACTION. Clin Exp Hypertens. 2021 Nov 17;43(8):801. doi: 10.1080/10641963.2018.1475654. Epub 2019 Jan 24. PMID: 30676090.
Copy Download .nbib Format: NLM
Hypertension, risk factors and coronary artery stenosis: A case-control study.

Clinical and experimental hypertension (New York, N.Y. : 1993)

Sedaghat Z, Zibaeenejad M, Fararouei M.
PMID: 29694250
Clin Exp Hypertens. 2018 Apr 25;1-6. doi: 10.1080/10641963.2018.1462376. Epub 2018 Apr 25.

Although hypertension is introduced as a major risk factor for cardiovascular diseases (CVDs), our knowledge about the nature of the association is hindered. The aim of this study was to assess the concurrent associations of several factors including serologic,...

Cite
Sedaghat Z, Zibaeenejad M, Fararouei M. Hypertension, risk factors and coronary artery stenosis: A case-control study. Clin Exp Hypertens. 2018;1-6doi: 10.1080/10641963.2018.1462376.
Sedaghat, Z., Zibaeenejad, M., & Fararouei, M. (2018). Hypertension, risk factors and coronary artery stenosis: A case-control study. Clinical and experimental hypertension (New York, N.Y. : 1993), 1-6. https://doi.org/10.1080/10641963.2018.1462376
Sedaghat, Zahra, et al. "Hypertension, risk factors and coronary artery stenosis: A case-control study." Clinical and experimental hypertension (New York, N.Y. : 1993) vol. (2018): 1-6. doi: https://doi.org/10.1080/10641963.2018.1462376
Sedaghat Z, Zibaeenejad M, Fararouei M. Hypertension, risk factors and coronary artery stenosis: A case-control study. Clin Exp Hypertens. 2018 Apr 25;1-6. doi: 10.1080/10641963.2018.1462376. Epub 2018 Apr 25. PMID: 29694250.
Copy Download .nbib Format: NLM
Left ventricular long-axis ultrasound strain (GLS) is an ideal indicator for patients with anti-hypertension treatment.

Clinical and experimental hypertension (New York, N.Y. : 1993)

Wu T, Zheng L, Zhang S, Duan L, Ma J, Zha L, Li L.
PMID: 34523366
Clin Exp Hypertens. 2022 Jan 02;44(1):20-25. doi: 10.1080/10641963.2021.1969663. Epub 2021 Sep 15.

BACKGROUND: Primary hypertension is one of the most well-known risk factors for cardiovascular disease. Currently, there is still no ideal indicator for left ventricular end-diastolic pressure.METHODS: 73 hypertension patients and 37 healthy people were enrolled in this study. Each...

Cite
Wu T, Zheng L, Zhang S, et al. Left ventricular long-axis ultrasound strain (GLS) is an ideal indicator for patients with anti-hypertension treatment. Clin Exp Hypertens. 2021;44(1):20-25doi: 10.1080/10641963.2021.1969663.
Wu, T., Zheng, L., Zhang, S., Duan, L., Ma, J., Zha, L., & Li, L. (2022). Left ventricular long-axis ultrasound strain (GLS) is an ideal indicator for patients with anti-hypertension treatment. Clinical and experimental hypertension (New York, N.Y. : 1993), 44(1), 20-25. https://doi.org/10.1080/10641963.2021.1969663
Wu, Tingting, et al. "Left ventricular long-axis ultrasound strain (GLS) is an ideal indicator for patients with anti-hypertension treatment." Clinical and experimental hypertension (New York, N.Y. : 1993) vol. 44,1 (2022): 20-25. doi: https://doi.org/10.1080/10641963.2021.1969663
Wu T, Zheng L, Zhang S, Duan L, Ma J, Zha L, Li L. Left ventricular long-axis ultrasound strain (GLS) is an ideal indicator for patients with anti-hypertension treatment. Clin Exp Hypertens. 2022 Jan 02;44(1):20-25. doi: 10.1080/10641963.2021.1969663. Epub 2021 Sep 15. PMID: 34523366.
Copy Download .nbib Format: NLM
Screening and early detection of chronic kidney disease at primary healthcare.

Clinical and experimental hypertension (New York, N.Y. : 1993)

Nagib SN, Abdelwahab S, Amin GEE, Allam MF.
PMID: 33726610
Clin Exp Hypertens. 2021 Jul 04;43(5):416-418. doi: 10.1080/10641963.2021.1896726. Epub 2021 Mar 17.

Chronic kidney disease (CKD) represents a global public health concern and results in poor health outcomes. While the burden of CKD is accurately well defined in developed countries, increasing evidence indicates that the CKD burden may be even greater...

Cite
Nagib SN, Abdelwahab S, Amin GEE, et al. Screening and early detection of chronic kidney disease at primary healthcare. Clin Exp Hypertens. 2021;43(5):416-418doi: 10.1080/10641963.2021.1896726.
Nagib, S. N., Abdelwahab, S., Amin, G. E. E., & Allam, M. F. (2021). Screening and early detection of chronic kidney disease at primary healthcare. Clinical and experimental hypertension (New York, N.Y. : 1993), 43(5), 416-418. https://doi.org/10.1080/10641963.2021.1896726
Nagib, Silvana Nader, et al. "Screening and early detection of chronic kidney disease at primary healthcare." Clinical and experimental hypertension (New York, N.Y. : 1993) vol. 43,5 (2021): 416-418. doi: https://doi.org/10.1080/10641963.2021.1896726
Nagib SN, Abdelwahab S, Amin GEE, Allam MF. Screening and early detection of chronic kidney disease at primary healthcare. Clin Exp Hypertens. 2021 Jul 04;43(5):416-418. doi: 10.1080/10641963.2021.1896726. Epub 2021 Mar 17. PMID: 33726610.
Copy Download .nbib Format: NLM
A review of BMP and Wnt signaling pathway in the pathogenesis of pulmonary arterial hypertension.

Clinical and experimental hypertension (New York, N.Y. : 1993)

Xin Z, Wang J, Li S, Sun C, Jiang W, Xin Q, Wang J, Qi T, Li K, Zhang Z, Luan Y.
PMID: 34821188
Clin Exp Hypertens. 2021 Nov 25;1-6. doi: 10.1080/10641963.2021.1996590. Epub 2021 Nov 25.

Pulmonary arterial hypertension (PAH) is a chronic disease characterized by a progressive elevation in mean pulmonary arterial pressure. This occurs due to abnormal remodeling of small peripheral lung vasculature resulting in progressive occlusion of the artery lumen that eventually...

Cite
Xin Z, Wang J, Li S, et al. A review of BMP and Wnt signaling pathway in the pathogenesis of pulmonary arterial hypertension. Clin Exp Hypertens. 2021;1-6doi: 10.1080/10641963.2021.1996590.
Xin, Z., Wang, J., Li, S., Sun, C., Jiang, W., Xin, Q., Wang, J., Qi, T., Li, K., Zhang, Z., & Luan, Y. (2021). A review of BMP and Wnt signaling pathway in the pathogenesis of pulmonary arterial hypertension. Clinical and experimental hypertension (New York, N.Y. : 1993), 1-6. https://doi.org/10.1080/10641963.2021.1996590
Xin, Zhihong, et al. "A review of BMP and Wnt signaling pathway in the pathogenesis of pulmonary arterial hypertension." Clinical and experimental hypertension (New York, N.Y. : 1993) vol. (2021): 1-6. doi: https://doi.org/10.1080/10641963.2021.1996590
Xin Z, Wang J, Li S, Sun C, Jiang W, Xin Q, Wang J, Qi T, Li K, Zhang Z, Luan Y. A review of BMP and Wnt signaling pathway in the pathogenesis of pulmonary arterial hypertension. Clin Exp Hypertens. 2021 Nov 25;1-6. doi: 10.1080/10641963.2021.1996590. Epub 2021 Nov 25. PMID: 34821188.
Copy Download .nbib Format: NLM
Triglyceride glucose index reflects the unfavorable changes of left ventricular diastolic functions and structure in uncomplicated newly diagnosed hypertensive patients.

Clinical and experimental hypertension (New York, N.Y. : 1993)

Cetin Sanlialp S, Sanlialp M, Nar G, Malcok A.
PMID: 34951339
Clin Exp Hypertens. 2021 Dec 24;1-8. doi: 10.1080/10641963.2021.2018599. Epub 2021 Dec 24.

INTRODUCTION: Left ventricular (LV) diastolic dysfunction and structural abnormalities are common cardiac changes in hypertension (HTN), and several factors other than high blood pressure (BP) may play a role in these changes. The aim of this study was to...

Cite
Cetin Sanlialp S, Sanlialp M, Nar G, et al. Triglyceride glucose index reflects the unfavorable changes of left ventricular diastolic functions and structure in uncomplicated newly diagnosed hypertensive patients. Clin Exp Hypertens. 2021;1-8doi: 10.1080/10641963.2021.2018599.
Cetin Sanlialp, S., Sanlialp, M., Nar, G., & Malcok, A. (2021). Triglyceride glucose index reflects the unfavorable changes of left ventricular diastolic functions and structure in uncomplicated newly diagnosed hypertensive patients. Clinical and experimental hypertension (New York, N.Y. : 1993), 1-8. https://doi.org/10.1080/10641963.2021.2018599
Cetin Sanlialp, Sara, et al. "Triglyceride glucose index reflects the unfavorable changes of left ventricular diastolic functions and structure in uncomplicated newly diagnosed hypertensive patients." Clinical and experimental hypertension (New York, N.Y. : 1993) vol. (2021): 1-8. doi: https://doi.org/10.1080/10641963.2021.2018599
Cetin Sanlialp S, Sanlialp M, Nar G, Malcok A. Triglyceride glucose index reflects the unfavorable changes of left ventricular diastolic functions and structure in uncomplicated newly diagnosed hypertensive patients. Clin Exp Hypertens. 2021 Dec 24;1-8. doi: 10.1080/10641963.2021.2018599. Epub 2021 Dec 24. PMID: 34951339.
Copy Download .nbib Format: NLM
Nocturnal non-dipping on 24-h Ambulatory Blood Pressure Monitoring in children and adolescents with obesity is associated with higher total cholesterol levels.

Clinical and experimental hypertension (New York, N.Y. : 1993)

Wójcik M, Stępień A, Bociąga M, Ciuk K, Januś D, Drożdż D, Starzyk JB.
PMID: 34617491
Clin Exp Hypertens. 2021 Oct 07;1-6. doi: 10.1080/10641963.2021.1984502. Epub 2021 Oct 07.

BACKGROUND: Few studies indicate the occurrence of abnormal nocturnal dipping of blood pressure (BP) in 35-50% of children and adolescents with obesity. The relation between that phenomenon and metabolic complications of obesity remains unclear. To evaluate the association between...

Cite
Wójcik M, Stępień A, Bociąga M, et al. Nocturnal non-dipping on 24-h Ambulatory Blood Pressure Monitoring in children and adolescents with obesity is associated with higher total cholesterol levels. Clin Exp Hypertens. 2021;1-6doi: 10.1080/10641963.2021.1984502.
Wójcik, M., Stępień, A., Bociąga, M., Ciuk, K., Januś, D., Drożdż, D., & Starzyk, J. B. (2021). Nocturnal non-dipping on 24-h Ambulatory Blood Pressure Monitoring in children and adolescents with obesity is associated with higher total cholesterol levels. Clinical and experimental hypertension (New York, N.Y. : 1993), 1-6. https://doi.org/10.1080/10641963.2021.1984502
Wójcik, Małgorzata, et al. "Nocturnal non-dipping on 24-h Ambulatory Blood Pressure Monitoring in children and adolescents with obesity is associated with higher total cholesterol levels." Clinical and experimental hypertension (New York, N.Y. : 1993) vol. (2021): 1-6. doi: https://doi.org/10.1080/10641963.2021.1984502
Wójcik M, Stępień A, Bociąga M, Ciuk K, Januś D, Drożdż D, Starzyk JB. Nocturnal non-dipping on 24-h Ambulatory Blood Pressure Monitoring in children and adolescents with obesity is associated with higher total cholesterol levels. Clin Exp Hypertens. 2021 Oct 07;1-6. doi: 10.1080/10641963.2021.1984502. Epub 2021 Oct 07. PMID: 34617491.
Copy Download .nbib Format: NLM
Pioglitazone restores phosphorylation of downregulated caveolin-1 in right ventricle of monocrotaline-induced pulmonary hypertension.

Clinical and experimental hypertension (New York, N.Y. : 1993)

Malikova E, Kmecova Z, Doka G, Pivackova LB, Balis P, Trubacova S, Velasova E, Krenek P, Klimas J.
PMID: 34747283
Clin Exp Hypertens. 2021 Nov 07;1-12. doi: 10.1080/10641963.2021.1996589. Epub 2021 Nov 07.

BACKGROUND: Caveolin-1 (cav-1) plays a role in pulmonary arterial hypertension (PAH). Monocrotaline (MCT)-induced PAH is characterized by a loss of cav-1 in pulmonary arteries; however, less is known regarding its role in the hypertrophied right ventricle (RV). We aimed...

Cite
Malikova E, Kmecova Z, Doka G, et al. Pioglitazone restores phosphorylation of downregulated caveolin-1 in right ventricle of monocrotaline-induced pulmonary hypertension. Clin Exp Hypertens. 2021;1-12doi: 10.1080/10641963.2021.1996589.
Malikova, E., Kmecova, Z., Doka, G., Pivackova, L. B., Balis, P., Trubacova, S., Velasova, E., Krenek, P., & Klimas, J. (2021). Pioglitazone restores phosphorylation of downregulated caveolin-1 in right ventricle of monocrotaline-induced pulmonary hypertension. Clinical and experimental hypertension (New York, N.Y. : 1993), 1-12. https://doi.org/10.1080/10641963.2021.1996589
Malikova, Eva, et al. "Pioglitazone restores phosphorylation of downregulated caveolin-1 in right ventricle of monocrotaline-induced pulmonary hypertension." Clinical and experimental hypertension (New York, N.Y. : 1993) vol. (2021): 1-12. doi: https://doi.org/10.1080/10641963.2021.1996589
Malikova E, Kmecova Z, Doka G, Pivackova LB, Balis P, Trubacova S, Velasova E, Krenek P, Klimas J. Pioglitazone restores phosphorylation of downregulated caveolin-1 in right ventricle of monocrotaline-induced pulmonary hypertension. Clin Exp Hypertens. 2021 Nov 07;1-12. doi: 10.1080/10641963.2021.1996589. Epub 2021 Nov 07. PMID: 34747283.
Copy Download .nbib Format: NLM
Renin-angiotensin system modulators in COVID-19 patients with hypertension: friend or foe?.

Clinical and experimental hypertension (New York, N.Y. : 1993)

Shylesh C M S, V S A, S K K, P UD.
PMID: 34414841
Clin Exp Hypertens. 2021 Aug 20;1-10. doi: 10.1080/10641963.2021.1963070. Epub 2021 Aug 20.

No abstract available.

Cite
Shylesh C M S, V S A, S K K, et al. Renin-angiotensin system modulators in COVID-19 patients with hypertension: friend or foe?. Clin Exp Hypertens. 2021;1-10doi: 10.1080/10641963.2021.1963070.
Shylesh C M, S., V S, A., S K, K., & P, U. D. (2021). Renin-angiotensin system modulators in COVID-19 patients with hypertension: friend or foe?. Clinical and experimental hypertension (New York, N.Y. : 1993), 1-10. https://doi.org/10.1080/10641963.2021.1963070
Shylesh C M, Shakhi, et al. "Renin-angiotensin system modulators in COVID-19 patients with hypertension: friend or foe?." Clinical and experimental hypertension (New York, N.Y. : 1993) vol. (2021): 1-10. doi: https://doi.org/10.1080/10641963.2021.1963070
Shylesh C M S, V S A, S K K, P UD. Renin-angiotensin system modulators in COVID-19 patients with hypertension: friend or foe?. Clin Exp Hypertens. 2021 Aug 20;1-10. doi: 10.1080/10641963.2021.1963070. Epub 2021 Aug 20. PMID: 34414841.
Copy Download .nbib Format: NLM
Left ventricular long-axis ultrasound strain (GLS) is an ideal indicator for patients with anti-hypertension treatment.

Clinical and experimental hypertension (New York, N.Y. : 1993)

Wu T, Zheng L, Zhang S, Duan L, Ma J, Zha L, Li L.
PMID: 34523366
Clin Exp Hypertens. 2021 Sep 15;1-6. doi: 10.1080/10641963.2021.1969663. Epub 2021 Sep 15.

BACKGROUND: Primary hypertension is one of the most well-known risk factors for cardiovascular disease. Currently, there is still no ideal indicator for left ventricular end-diastolic pressure.METHODS: 73 hypertension patients and 37 healthy people were enrolled in this study. Each...

Cite
Wu T, Zheng L, Zhang S, et al. Left ventricular long-axis ultrasound strain (GLS) is an ideal indicator for patients with anti-hypertension treatment. Clin Exp Hypertens. 2021;1-6doi: 10.1080/10641963.2021.1969663.
Wu, T., Zheng, L., Zhang, S., Duan, L., Ma, J., Zha, L., & Li, L. (2021). Left ventricular long-axis ultrasound strain (GLS) is an ideal indicator for patients with anti-hypertension treatment. Clinical and experimental hypertension (New York, N.Y. : 1993), 1-6. https://doi.org/10.1080/10641963.2021.1969663
Wu, Tingting, et al. "Left ventricular long-axis ultrasound strain (GLS) is an ideal indicator for patients with anti-hypertension treatment." Clinical and experimental hypertension (New York, N.Y. : 1993) vol. (2021): 1-6. doi: https://doi.org/10.1080/10641963.2021.1969663
Wu T, Zheng L, Zhang S, Duan L, Ma J, Zha L, Li L. Left ventricular long-axis ultrasound strain (GLS) is an ideal indicator for patients with anti-hypertension treatment. Clin Exp Hypertens. 2021 Sep 15;1-6. doi: 10.1080/10641963.2021.1969663. Epub 2021 Sep 15. PMID: 34523366.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 67 entries